A Korean research team has recently confirmed that keratin, the main component of human hair, can be beneficial for hair growth. Human trials of a new, injectable keratin-based treatment for hair loss, developed by Korean bio-venture company KeraMedix, are expected to begin soon.
A joint research team from South Korea’s Kyung Hee University and Konkuk University, together with KeraMedix, announced on Nov. 24 that it has identified the mechanism of keratin in hair growth through animal experiments on mice. The research results were published in the journal Communications Biology on Nov. 19.





